News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,865 Results
Type
Article (14291)
Company Profile (283)
Press Release (253291)
Section
Business (79831)
Career Advice (157)
Deals (13292)
Drug Delivery (35)
Drug Development (50499)
Employer Resources (31)
FDA (5734)
Job Trends (5146)
News (144838)
Policy (10053)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (930)
Accelerated approval (2)
Adcomms (12)
Allergies (50)
Alliances (21703)
ALS (62)
Alzheimer's disease (843)
Antibody-drug conjugate (ADC) (89)
Approvals (5753)
Artificial intelligence (113)
Autoimmune disease (13)
Automation (5)
Bankruptcy (105)
Best Places to Work (4577)
BIOSECURE Act (5)
Biosimilars (41)
Biotechnology (232)
Bladder cancer (46)
Brain cancer (20)
Breast cancer (142)
Cancer (1326)
Cardiovascular disease (113)
Career advice (136)
Career pathing (2)
CAR-T (108)
Cell therapy (309)
Cervical cancer (8)
Clinical research (40967)
Collaboration (504)
Compensation (240)
Complete response letters (13)
COVID-19 (1038)
CRISPR (38)
C-suite (148)
Cystic fibrosis (76)
Data (1400)
Denatured (11)
Depression (29)
Diabetes (127)
Diagnostics (1320)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (80)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (84)
Earnings (29766)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48396)
Executive appointments (415)
FDA (6374)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (476)
Gene editing (91)
Generative AI (10)
Gene therapy (236)
GLP-1 (359)
Government (1083)
Grass and pollen (2)
Guidances (18)
Healthcare (6645)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (82)
Indications (18)
Infectious disease (1104)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (21)
Intellectual property (59)
Interviews (17)
IPO (7293)
IRA (11)
Job creations (863)
Job search strategy (130)
Kidney cancer (6)
Labor market (4)
Layoffs (206)
Leadership (3)
Legal (1397)
Liver cancer (30)
Lung cancer (189)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (119)
MASH (50)
Medical device (2611)
Medtech (2612)
Mergers & acquisitions (6300)
Metabolic disorders (368)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1230)
NextGen: Class of 2025 (2045)
Non-profit (885)
Northern California (1586)
Now hiring (21)
Obesity (186)
Opinion (101)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (51)
Parkinson's disease (115)
Partnered (8)
Patents (113)
Patient recruitment (68)
Peanut (35)
People (25673)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (14467)
Phase II (19060)
Phase III (12055)
Pipeline (753)
Podcasts (47)
Policy (39)
Postmarket research (854)
Preclinical (6075)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (280)
Real estate (1429)
Recruiting (12)
Regulatory (8590)
Reports (15)
Research institute (946)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (93)
Series B (61)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1405)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1981)
State (1)
Stomach cancer (4)
Supply chain (19)
Tariffs (3)
The Weekly (35)
United States (12389)
Vaccines (207)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (37)
Last 7 days (295)
Last 30 days (1555)
Last 365 days (19852)
2025 (5070)
2024 (20612)
2023 (22475)
2022 (26880)
2021 (27880)
2020 (23474)
2019 (16324)
2018 (11807)
2017 (13784)
2016 (11892)
2015 (14416)
2014 (10433)
2013 (7514)
2012 (7561)
2011 (7648)
2010 (7443)
Location
Africa (152)
Alabama (39)
Alaska (2)
Arizona (53)
Arkansas (6)
Asia (17252)
Australia (2936)
California (3596)
Canada (1067)
China (327)
Colorado (138)
Connecticut (145)
Delaware (89)
Europe (37152)
Florida (428)
Georgia (110)
Idaho (16)
Illinois (219)
India (9)
Indiana (91)
Iowa (1)
Japan (72)
Kansas (60)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (451)
Massachusetts (2849)
Michigan (69)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (903)
New Mexico (12)
New York (974)
North Carolina (528)
North Dakota (4)
Northern California (1586)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (684)
Puerto Rico (3)
Rhode Island (15)
South America (210)
South Carolina (5)
Southern California (1405)
Tennessee (25)
Texas (413)
Utah (52)
Virginia (70)
Washington D.C. (29)
Washington State (327)
Wisconsin (13)
267,865 Results for "knight therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Univec, Inc. Welcomes Michael Knight to Board of Directors
January 17, 2025
·
1 min read
BioMidwest
Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
Asha Therapeutics announced today that it has been selected as a BLUE KNIGHT™ company.
September 22, 2023
·
3 min read
Press Releases
Waters Corporation Appoints Heather Knight to Board of Directors
August 15, 2024
·
2 min read
BioForest
HDT Bio Receives $1 Million Award from BLUE KNIGHT™ Resident QuickFire Challenge in Support of Project NextGen
HDT Bio Corp. announced that it has received a $1 million award from the BLUE KNIGHT™ Resident QuickFire Challenge.
October 4, 2023
·
2 min read
Genetown
Adrestia Co-Founder Professor Steve Jackson Named Knight Bachelor for Services to Innovation and Research
Adrestia Therapeutics announced its co-founder, Professor Steve Jackson FRS FMedSci, has been named a Knight Bachelor in the 2023 Birthday Honours List, which announces the bestowing of various awards and designations on the King’s Birthday in the United Kingdom.
June 16, 2023
·
4 min read
Business
Integra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer
Integra LifeSciences Holdings Corporation announced the appointment of Lea Daniels Knight as executive vice president and chief financial officer, effective June 28, 2023.
June 21, 2023
·
4 min read
Business
Immunyx Pharma Selected to Join BLUE KNIGHT™
Immunyx Pharma announced it has been selected to join Blue Knight , a collaboration between Johnson & Johnson Innovation LLC and the Biomedical Advanced Research and Development Authority (‘BARDA’) within the Administration for Strategic Preparedness and Response (ASPR), a part of the U.S. Department of Health and Human Services, (HHS).
January 23, 2023
·
2 min read
Business
HDT Bio Selected to Join BLUE KNIGHT™
HDT Bio Corp. announced it has been selected to join Blue Knight, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response, a part of the U.S. Department of Health and Human Services.
November 7, 2022
·
3 min read
Press Releases
Tasman Therapeutics Advancing Oral Ketamine Program to Pivotal Phase 3 Studies
April 3, 2025
·
7 min read
Biotech Bay
Heather Knight Joins Channel Medsystems Board of Directors
Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, announced that Heather Knight has joined the company’s Board of Directors.
August 3, 2022
·
3 min read
1 of 26,787
Next
